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a b s t r a c t 
Background: Cirrhosis-associated immune dysfunction (CAID) contributes to high sepsis risk in patients 
with chronic liver disease. Various innate and; to a lesser extent; adaptive immune dysfunctions have 
been described as contributors to CAID leading to immune-paresis and impaired anti-microbial response 
in cirrhosis. In this study, we examined the phenotype of CD8 + T cells in chronic liver disease with the 
aim to evaluate changes that might contribute to impaired immune responses. 
Methods: Sixty patients with cirrhosis were prospectively recruited for this study. CD8 + T cells from 
peripheral blood, ascites and liver explants were characterized using ﬂow cytometry and immunohisto- 
chemistry, respectively. The transcriptional signature of ﬂow-sorted HLA-DR + CD8 + T cells was performed 
using Nanostring TM technology. HLA-DR + CD8 + T cells interactions with PBMCs and myeloid cells were 
tested in vitro . 
Findings: Peripheral CD8 + T cells from cirrhotic patients displayed an altered phenotype characterized by 
high HLA-DR and TIM-3 surface expression associated with concomitant infections and disease severity, 
respectively. Paired peritoneal CD8 + T cells expressed more pronounced levels of HLA-DR and PD-1 com- 
pared to peripheral CD8 + T cells. HLA-DR + CD8 + T cells were enriched in cirrhotic livers compared to con- 
trols. TIM-3, CTLA-4 and PD-1 levels were highly expressed on HLA-DR + CD8 + T cells and co-expression 
of HLA-DR and PD1 was higher in patients with poor disease outcomes. Genes involved in cytokines pro- 
duction and intracellular signalling pathways were strongly down-regulated in HLA-DR + CD8 + T cells. In 
comparison to their HLA-DR − counterparts, HLA-DR + CD8 + T cells promoted less proliferation of PBMCs 
and induced phenotypic and functional dysfunctions in monocytes and neutrophils in vitro . 
Interpretation: In patients with cirrhosis, CD8 + T cells display a phenotypic, functional and transcriptional 
proﬁle which may contribute to CAID. 
Fund: This work was supported by Medical Research Council, the Rosetrees Charitable Trust, Robert Tour- 
nut 2016 grant (Sociéte Nationale Française de GastroEntérologie), Gilead® sciences, and NIHR Imperial 
Biomedical Research Centre. 
© 2019 The Author(s). Published by Elsevier B.V. 
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EResearch in context 
Evidence before this study 
Infections represent a major issue in the management 
of patients with end-stage liver diseases (ELD). Cirrhosis- 
associated immune dysfunction (CAID) contributes to high 
sepsis risk and poor outcomes in patients with cirrhosis. We 
and others have shown the importance of innate immune 
dysfunction in the pathogenesis of infection susceptibility in 
acute and chronic liver failure. However, the impact of adap- 
tive immune defects has not been fully explored. Here, we 
evaluate and characterize CD8 + T cells in patients with cir- 
rhosis. 
Added value of this study 
We show that in patients with cirrhosis, total CD8 + 
T cells express an activated dysfunctional proﬁle charac- 
terized by an expansion of an immunosuppressive HLA- 
DR + CD8 + T cell subset in peripheral, peritoneal and intra- 
hepatic compartments. HLA-DR expression by CD8 + T cells 
was higher in patients who developed infection compared 
to the ones who did not. Co-expression of PD-1 and HLA- 
DR was associated with poor outcomes. We reveal that HLA- 
DR + CD8 + T cells exhibit a down-regulation of genes involved 
in pro-inﬂammatory cytokines production and intracellular 
signalling pathways with the capacity to promote low pro- 
liferative responses in autologous peripheral blood mononu- 
clear cells (PBMCs) and to induce dysfunctions in myeloid 
cells. 
Implications of all the available evidence 
We reveal that in patients with cirrhosis, CD8 + T cells dis- 
play a phenotypic, functional and transcriptional proﬁle that 
may impact susceptibility to infection and disease outcome. 
Further studies are needed to determine circulating soluble 
factors involved in the expansion of HLA-DR + CD8 + T cell and 
to identify targets to counteract adaptive immune defects in 
cirrhosis. 
1. Introduction 
Infections represent a turning point in the natural progression
course of cirrhosis and are the main precipitant event for liver in-
suﬃciency associated with multi-organ failure, a condition referred
to as “Acute-on-chronic liver failure” (ACLF) [1–4] . Increased sus-
ceptibility to infection and the severe prognosis of septic episodes
have been associated with cirrhosis-associated immune dysfunc-
tion (CAID); a dynamic pattern of immune responses shifting from
a predominantly pro-inﬂammatory to an anti-inﬂammatory com-
pensatory response [5] . Innate immune dysfunctions in CAID have
been well described. In patients presenting alcohol-related liver
diseases (ALD), profound impaired oxidative burst and bacterici-
dal functions of polymorphonuclear neutrophils (PMNs) and mono-
cytes were observed [6–10] . In patients with acute liver failure
(ALF) and ACLF, pro-inﬂammatory conditions could drive an in
vivo anti-inﬂammatory monocyte phenotype which was associated
with a defective anti-bacterial response in vitro [11–13] . We re-
cently identiﬁed that monocytes from ALF and ACLF patients, and
to a lesser extent from patients with cirrhosis without organ fail-
ure, exhibit an immune regulatory HLA-DR High MER-TK + phenotype
[11,12] . Additionally, we reported an expansion of myeloid-derived
suppressors CD14 + CD15 −HLA-DR − cells in patients with ACLF [13] .
Although partially explored, adaptive immune defects are im-
portant drivers of immune-paresis and susceptibility to infection
in liver diseases. We and others have provided evidence that im-
paired antimicrobial responses in ALF and alcoholic acute hepatitis
(AAH) were mediated by an altered phenotype of CD4 + and CD8 + 
T lymphocytes characterized by elevated levels of immune check-
points PD-1, TIM-3 and CTLA-4 [10,14] . Please cite this article as: F. Lebossé, C. Gudd and E. Tunc et al., CD8+ 
contribute to cirrhosis-associated immune dysfunction, EBioMedicine, hCD8 + T cells can display a dysfunctional proﬁle induced by
hronic antigen stimulation in the context of chronic viral infec-
ions or tumours [15] . Recently, a new subset of regulatory CD8 + 
 cells with suppressive properties in vitro has been discovered in
eripheral blood of healthy volunteers (HV) and umbilical blood
f new-borns, sharing activated and exhausted CD8 + T cells char-
cteristics, such as HLA-DR, CTLA-4 and PD-1 surface expression
16,17] . 
This study provides a detailed phenotypic, functional and tran-
criptional characterization of CD8 + T cells in cirrhotic patients.
e reveal new insights on the impact of HLA-DR + CD8 + T cells on
AID. 
. Materials and methods 
.1. Patients 
A total of 60 patients with end stage liver diseases (ELD)
ere prospectively recruited from February 2016 to October 2017
 Table 1 ). Twenty ﬁve patients with compensated cirrhosis (chronic
iver disease (CLD)) were recruited to the study from outpatient
epatology clinics, Imperial College NHS Healthcare Trust. Cirrhotic
atients with acute decompensation (AD; n = 35) were enrolled
ithin 48 h following admission. Twenty seven healthy volunteers
HV) served as healthy controls. Patients with cirrhosis were in-
luded based on liver biopsy, clinical presentation suggestive of cir-
hosis and/or on radiological assessment. Clinical data were col-
ected for 1 year after enrolment, with 5 patients being lost to
ollow-up. Underlying liver diseases and exclusion criteria are de-
cribed in Supporting Methods. 
.2. Ethics approval 
The study was approved by local research ethic committees
12/LO/0167). Informed consent was obtained by the next of kin
f patients were not able to provide consent. 
.3. Isolation of mononuclear and polymophonuclear cells 
Peripheral blood mononuclear cells (PBMCs), ascites mononu-
lear cells (AMNCs), fresh PMNs and monocytes were isolated as
escribed in Supporting Methods. 
.4. Phenotyping and intracellular staining 
CD8 + T cells were phenotyped using cell surface and intra-
ellular staining as described in Supporting Methods. Multicolor
ow cytometry analyses were performed on LSRFortessa TM ﬂow
ytometer, data were acquired using BD FACSDiva TM software (Bec-
on Dickinson Ltd, Oxford, UK) and analyses were performed using
lowLogic software (Inivai Technologies, Pty Ltd). 
.5. Immunohistochemistry 
Explanted liver tissue was obtained from patients undergo-
ng orthotopic liver transplantation (OLT) for cirrhosis (alcoholic
iver disease (ALD); n = 4 and non-alcoholic steatohepatitis (NASH);
 = 4). Hepatic resection margins of colorectal metastases ( n = 4)
erved as pathological controls. Double epitope immunohistochem-
stry (CD8 & HLA-DR) was performed for all cases followed by
nalysis using the Nuance multispectral imaging system (Perkin
lmer, Beaconsﬁeld, UK) [12] (Supporting Methods). T cells from patients with cirrhosis display a phenotype that may 
ttps://doi.org/10.1016/j.ebiom.2019.10.011 
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d  .6. Transcriptional analyses 
Viable CD3 + CD8 + T cells were sorted into CD3 + CD8 + HLA-DR + 
r CD3 + CD8 + HLA-DR − using FACS Aria II ﬂow cytometer (Bec-
on Dickinson Ltd, Oxford, UK) (gating strategy described in Fig.
1 a). NanoString nCounter® Immunology v2 Panel (NanoString TM ,
eattle, USA) proﬁling 579 genes involved in immune response
as then performed and gene expression was compared in paired
D8 + HLA-DR − and CD8 + HLA-DR + T cells from HV ( n = 3) or pa-
ients ( n = 3). Analyses were carried out using the nSolver TM Anal-
sis Software 3.0. Genes were identiﬁed according to gene ontology
nnotation. 
.7. Cell stimulation and measurement of cytokines production 
HLA-DR + CD8 + T cells were puriﬁed using a multi-step mag-
etic cell separation isolation process (Supporting Methods). HLA-
R − or HLA-DR + CD8 + T cell subsets from HV or patients with
irrhosis were stimulated for 2 days with Dynabeads® human T-
ctivator CD3/CD28 (Life Technologies Limited, Paisley, UK) at 1:1
ead to cell ratio. Supernatants were collected and assessed for cy-
okines production using a Multiplex Cytokines Detection System
-Plex Proinﬂammatory Panel 1 kit (Meso Scale Discovery (MSD),
ockville, USA) according to the manufacturer’s instructions. 
.8. Assessment of CD8 + T cells regulatory effect on autologous 
BMCs proliferation 
Total PBMCs from HV or patients with cirrhosis were cultured
or 3 days either alone or in presence of pre-isolated autologous
LA-DR − or HLA-DR + CD8 + T cells (1:2 T cell to PBMCs ratio)
n the presence of CD3/CD28 beads (1:4 bead to PBMCs ratio).
roliferation of responders PBMCs was measured using carboxyﬂu-
rescein succinimidyl ester (CFSE) labelling (Life Technologies
imited, Paisley, UK) in the presence or absence of anti-CTLA-4,
nti-PD-1 (Life Technologies Limited, Paisley, UK) or anti-TIM3 (Bi-
legend, California, USA) blocking antibodies (all used at 10 μg/ml).
ytokines production in blocking experiment was assessed using
SD V-Plex Proinﬂammatory Panel 1 kit (MSD, Rockville, USA). 
.9. Phenotypic assessment of myeloid cells following co-culture with 
LA-DR + CD8 + T cells 
CD8 + T cells pre-conditioned in plasma from cirrhotic patients
Supporting Methods) were co-cultured with bead-isolated neu-
rophils or monocytes at a 1:2 T cell to myeloid cell ratio in
he presence of anti-CD3 (0.5 μg/mL) (Life Technologies Limited,
aisley, UK). Following 24hr co-cultures, neutrophils or monocytesTABLE 1 
Clinical characteristics 1 . 
ALL P
Age ∗ (years) 2 54.6 (
Sex (Male/ total (n)) 36 / 6
ALD (ALD / total (n)) 47 / 6
Sepsis (sepsis / total (n)) 14 / 6
Cause of AD AAH / sepsis / other / undetermined (n) –
MELD-Na score ∗∗ 16 (10
CHILD PUGH score ∗∗ 9 (8 –
Leukocytes count ∗ (x 10 9 /L) 7.0 (4
Lymphocytes count (x 10 9 /L) 1.1 (0
Monocytes count ∗ (x 10 9 /L) 0.7 (0
Neutrophils count ∗ (x 10 9 /L) 4.6 (3
CRP ∗ (mg/L) 20.2 (
1 Data are presented as median values (1st – 3rd quartile). 
2 Median age of healthy control group ( n = 27) was 39 (31–52)
and AD; ∗∗ p < 0.0 0 01 between CLD and AD. 
Please cite this article as: F. Lebossé, C. Gudd and E. Tunc et al., CD8+ T
contribute to cirrhosis-associated immune dysfunction, EBioMedicine, here assessed for phenotypic expression of CD16, CD64, CD11b,
D62L, CD66b and CD177 cell surface markers on neutrophils or
D1, CD163, HLA-DR, CD14 and MerTK on monocytes. 
.10. Assessment of neutrophils phagocytic capacity and cytokine 
roduction following co-culture with HLA-DR + CD8 + T cells 
Neutrophils were assessed for their ability to phagocytize E. coli
 E. coli ) following 4 hrs co-culture with HLA-DR + CD8 + T cells using
Hrodo TM Red E. coli BioParticles (Lifetechnologies, UK) following
he manufacturer’s protocol. Levels of TNF- α and IL-8 expression in
eutrophils in response to E. coli lipopolysaccharide (LPS) stimula-
ion (100 ng/mL) were measured using intracellular cytokine stain-
ng. 
.11. Statistical analysis 
Mann-Whitney test was used for nonparametric data. Wilcoxon
atched-pairs signed rank test and paired t-test were used for
aired tests. Spearman correlation coeﬃcients were calculated.
ene expression is reported as fold change of detected mRNA ex-
ression levels normalised to baseline values observed in HLA-
R −CD8 + . Statistical signiﬁcance was assumed for P values ≤ 0.05.
ata analysis was performed using GraphPad Prism 5 (GraphPad
oftware Inc., San Diego, CA). 
. Results 
.1. Clinical characteristics 
Twenty ﬁve stable cirrhotic patients (CLD) and thirty ﬁve pa-
ients admitted for decompensation of cirrhosis (AD) were re-
ruited into this study. The median age of the cohort was 54.6
ears old, 60% were male, principally suffering of ALD ( Table 1 ).
AH was the precipitating factor for 10 AD patients ( Table 1 ). Me-
ian MELD score was 18 in the overall cohort and signiﬁcantly in-
reased with acute decompensation ( Table 1 ). Leukocytes, mono-
ytes and neutrophils counts as well as C-Reactive Protein levels
n patients with AD were signiﬁcantly higher compared to patients
ith CLD ( Table 1 ). 
.2. Peripheral CD8 + T cells from cirrhotic patients display an altered 
henotype 
In line with previous reports [5,14,18] , the proportion of
irculating CD8 + T cells in cirrhotic patients was signiﬁcantly
iminished compared to HV (median values: 8.99% vs 19.85%atients ( n = 60) CLD ( n = 25) AD ( n = 35) 
48.3 – 63.0) 56.3 (52.7 – 71.3) 52.4 (44.6 – 58) 
0 15 / 25 21 / 35 
0 18 / 25 29 / 35 
0 0 / 25 14 / 35 
– 10 / 8 / 8 / 9 
 – 21) 10 (9 – 16) 22 (18 – 28) 
11) 8 (6 – 10) 10 (9 – 11) 
.7 – 9.5) 5.6 (4.3 – 7.4) 8.1 (4.7 – 12.3) 
.8 – 1.7) 1.1 (0.7 – 1.8) 1.1 (0.8 – 1.6) 
.5 – 1.0) 0.6 (0.4 – 0.8) 0.9 (0.6 – 1.2) 
.1 – 6.8) 3.8 (2.8 – 5.4) 5.5 (3.1 – 8.5) 
7.4 – 35.6) 5.9 (4.8 – 21.7) 24.7 (16.4 – 44) 
 years old).Mann Whitney U Test: ∗ p < 0.05 between CLD 
 cells from patients with cirrhosis display a phenotype that may 
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Fig 1. Phenotype of total CD8 + T cells in cirrhotic patients assessed by ﬂow cytometry. (a) Lower proportion and altered phenotype of total circulating CD8 + T cells in 
cirrhotic patients ( n = 60) compared to total circulating CD8 + T cells in healthy volunteers (HV) ( n = 27): proportion from peripheral blood mononuclear cells (PBMCs) 
(left panel), baseline intracellular functional markers (middle left panel), expression of maturation surface markers (middle right panel), activation and inhibition surface 
markers (right panel) were assessed by extra- or intra-cellular staining following live / dead exclusion. (b) Phenotype of total circulating CD8 + T cells in cirrhotic patients 
according to disease severity: comparison of circulating CD8 + T cells phenotype in HV ( n = 27), stable chronic cirrhotic patients (chronic liver diseases (CLD)) ( n = 25) and 
acute decompensated (AD) patients ( n = 35). (c) Intra-peritoneal total CD8 + T cells (isolated from ascites of cirrhotic patients, n = 7): proportion of CD8 + T cells from ascites 
mononuclear cells (AMNCs) comparde to paired peripheral blood (left panel), percentage of expression of activation and inhibition surface markers (right panel). ∗ p < 0.05; 
∗∗ p < 0.0 0 01 (Mann-Whitney U test (A; B) and Wilcoxon signed-rank test (C)). 
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i  respectively; p < 0.0 0 01). Furthermore, analyses of cytolytic me-
diators in CD8 + T cells from patients with cirrhosis showed
signiﬁcantly decreased perforin expression compared to HV (me-
dian values 18.05% vs 47.53%, respectively; p = 0.049) ( Fig. 1 a).
No signiﬁcant changes were detected in intracellular granzyme
B levels or in the surface expression of T cell markers (CD45RO,
CD45RA, CCR7 and CD62L) ( Fig. 1 a). T cell activation and inhibition
markers however were markedly elevated in patients with cirrho-
sis (HLA-DR; p < 0.0 0 01 and TIM-3; p = 0.0 0 02) in comparison to
HV ( Fig. 1 a). The increase in HLA-DR expression on CD8 + T cells in
cirrhosis was independent of disease severity ( Fig. 1 b). Conversely,
higher levels of TIM-3 were particularly noted in patients with AD
( Fig. 1 b). This phenotype was not altered by disease aetiology (ALD
vs non-ALD) or recent alcohol intake, with the exception of TIM-3
expression which was more pronounced in patients with recent
alcohol consumption ( Fig. S1 b). AAH as a precipitating factor for
AD did not affect the reported CD8 + T cell phenotype ( Fig. S1 c). 
3.3. Peritoneal CD8 + T cells share similar characteristics with 
matched peripheral CD8 + T cells in cirrhotic patients with ascites 
Expression of immune phenotypic markers on CD8 + T cells
from cirrhotic patients with ascites, without spontaneous bacte-
rial complications, was assessed and compared to paired periph-
eral blood CD8 + T cells. Although similar in proportion, peri-
toneal CD8 + T cells expressed greater levels of HLA-DR ( p = 0.03)
( Fig. 1 c). Additionally, inhibitory receptor PD-1 was signiﬁcantly
up-regulated on peritoneal compared to peripheral CD8 + T cellsPlease cite this article as: F. Lebossé, C. Gudd and E. Tunc et al., CD8+ 
contribute to cirrhosis-associated immune dysfunction, EBioMedicine, h p = 0.01) ( Fig. 1 c). No signiﬁcant differences were detected in the
xpression of other T cell markers ( Fig. S1 d). 
.4. HLA-DR + CD8 + T cells are enriched in the liver of cirrhotic 
atients 
Considering our results showing pronounced HLA-DR expres-
ion of peripheral and peritoneal CD8 + T cells, we tested whether
D8 + T cells in the liver featured similar characteristics. We reveal
hat HLA-DR + CD8 + T cells were enriched in liver explants from cir-
hotic patients (ALD; n = 4 and NASH; n = 4). Despite no changes in
he overall CD8 + T cells number, immunohistochemistry revealed a
igniﬁcantly higher proportion of HLA-DR + CD8 + T cells in cirrhotic
iver tissues compared to non-cirrhotic pathological controls (me-
ian 60.75% vs 22.2%, respectively; p = 0.048) ( Fig. 2 a and b). In the
xplants from patients with cirrhosis, HLA-DR + CD8 + T cells were
ore enriched in the hepatic plates than in the porto-septal areas
median 60.75% vs 19.32% respectively; p = 0.001) ( Fig. 2 b and 2 c).
o difference was reported according to disease aetiology (data not
hown). 
.5. Correlation between elevated markers, disease severity indices 
nd susceptibility to infections in CLD 
When assessed for correlation with disease severity indices, el-
vated levels of TIM-3 on total CD8 + T cells correlated positively
ith MELD score ( r = 0.35; p = 0.02) ( Fig. 3 a). We reveal a signif-
cant association between the proportion of TIM-3 + CD8 + T cellsT cells from patients with cirrhosis display a phenotype that may 
ttps://doi.org/10.1016/j.ebiom.2019.10.011 
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Fig 2. Characterization of intrahepatic CD8 + T cells in cirrhotic patients and pathological controls: Immunohistochemistry was performed on formalin-ﬁxed and paraﬃn- 
embedded explanted liver tissue from cirrhotic patients ( n = 8) and hepatic resection margins of colorectal metastases as pathological controls ( n = 4). Micrographs were 
analyzed using the Nuance multispectral imaging system to obtain (a) the number of CD8 + T cells/10 random high-power ﬁelds (HPF) in hepatic plates (left panel) and 
porto-septal areas (right panel), and (b) the proportion of HLA-DR + cells within the intrahepatic CD8 + T cell contingent per 10 random HPF. ∗ p < 0.05. (c) Representative mi- 
crographs for CD8/HLA-DR double epitope enzymatic immunohistochemistry in pathological controls (left panel) and cirrhotic livers (right panel) (400x); left columns: bright 
ﬁeld micrographs showing CD8 + cells in red, and HLA-DR + cells in green, with hematoxylin as nuclear counterstaining; right columns: corresponding pseudo-ﬂuorescent 
micrographs showing CD8 + cells in red, HLA-DR + cells in green, nuclei in blue, and co-localization of CD8 and HLA-DR signals in yellow. (Scale bars: 50 μm for 400x mag- 
niﬁcation; 20 μm for insets). (Man-Whitney U test for comparison between cirrhotic patients and pathological controls; Wilcoxon signed-rank test for comparison between 
hepatic plates and porto-septal areas). 
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Dnd HLA-DR + CD8 + T cells ( Fig. S1 e). Expression of HLA-DR on
D8 + T cells did not correlate with MELD score ( Fig. S1 f). However,
LA-DR + CD8 + T cells were signiﬁcantly higher in patients with AD
resenting with concomitant sepsis at admission ( Fig. 3 b). 
.6. Characterization of the expanded HLA-DR + CD8 + T cell population
n cirrhotic patients and association with poor outcomes 
Subsequent detailed analyses of the HLA-DR + CD8 + T cell subset
ere carried out in cirrhotic patients and revealed that when com-
ared to their HLA-DR − counterparts, these cells exhibited a T cen-
ral memory (Tcm) phenotype highlighted by low expression of the
aïve T cell marker CD45RA (23.80% vs 67.89%, p < 0.0 0 01) and high
evels of the lymph node homing marker, CD62L ( Fig. 4 a). We also
bserved signiﬁcantly enhanced levels of perforin and granzyme B
n HLA-DR + CD8 + T cells compared to paired HLA-DR −CD8 + T cells
rom cirrhotic patients ( p = 0.012) ( Fig. 4 a). However, perforin lev-
ls in HLA-DR + CD8 + T cells from patients remained signiﬁcantly
ower in comparison to the levels seen in HLA-DR + CD8 + T cells
rom HV ( Fig. S2 a). Similarly, HLA-DR + CD8 + T cells from cirrhoticPlease cite this article as: F. Lebossé, C. Gudd and E. Tunc et al., CD8+ T
contribute to cirrhosis-associated immune dysfunction, EBioMedicine, hatients displayed high levels of activation markers (CD28, CD56
nd CD69) and signiﬁcant increase in inhibitory markers CTLA-4
 p < 0.0 0 01), PD-1 ( p < 0.0 0 01), TIM-3 ( p < 0.0 0 01) and the effector
arker FAS-L ( p = 0.002) ( Fig. 4 b). HLA-DR + CD8 + T cells expressing
igh levels of PD-1 were associated with poor disease outcomes
 Fig. 4 c). 
Functional assessment following CD3/CD28 beads stimulation 
evealed no differences in secreted levels of IFN- γ , TNF- α or IL-2
n paired HLA-DR + versus their HLA-DR −CD8 + counterparts from
irrhotic patients ( Fig. 4 d). However, HLA-DR + CD8 + T cells from
V produced signiﬁcantly lower levels of TNF- α ( p = 0.02) and IL-2
 p = 0.008) (Fig. S2 b ). 
.7. HLA-DR + CD8 + T cells in patients with cirrhosis differ from 
lassical regulatory, NKT and MAIT cells 
In line with previous reports [16,19] , levels of CD25 + FOX-P3 + 
ouble positivity in the HLA-DR + CD8 + T cell population were neg-
igible in cirrhotic patients as well as in HV ( Fig. 4 b and Fig. S2 c).
espite high levels of markers known not to be restricted to CD8 +  cells from patients with cirrhosis display a phenotype that may 
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Fig 3. CD8 + T cells phenotype in cirrhotic patients and association with disease severity and infection. (a) TIM-3 expression on CD8 + T cells surface correlated positively with 
MELD score ( n = 44). (b) The proportion of HLA-DR + CD8 + T cells in AD ( n = 35) was increased in patients with concomitant proven sepsis ( n = 13) compared to non-septic 
patients ( n = 22). ∗ p < 0.05 (Spearman correlation (a) and Mann-Whitney U test (b)). 
Fig 4. Detailed phenotypic and functional characterization of HLA-DR + CD8 + T cells in cirrhotic patients. (a) Expression of maturation surface markers (left panel; n = 60) 
and baseline intracellular functional markers (right panel) in HLA-DR −CD8 + T cells compared to HLA-DR + CD8 + T cells. (b) Expression of activation and inhibition surface 
markers, including expression of T-regulator cells markers (CD25 and FOXP-3). (c) Elevated frequency of CD8 + T cells co-expressing PD1 and HLA-DR in patients with poor 
outcomes. (d) In vitro cytokines production of HLA-DR −CD8 + and HLA-DR + CD8 + T cells isolated from cirrhotic patients following 48 h CD3/CD28 beads stimulation ( n = 10). 
(e) Co-expression of natural killer T (NKT) (left panel) and mucosal-associated invariant T (MAIT) cell markers (right panel) on HLA-DR + CD8 + T cells from HV ( n = 4 and 
n = 9, respectively) and cirrhotic patients ( n = 10 and n = 18 respectively). ∗ p < 0.05; ∗∗ p < 0.0 0 01 (Wilcoxon signed-rank test (a; b; d; e) and Mann-Whitney U test (c)). 
Please cite this article as: F. Lebossé, C. Gudd and E. Tunc et al., CD8+ T cells from patients with cirrhosis display a phenotype that may 
contribute to cirrhosis-associated immune dysfunction, EBioMedicine, https://doi.org/10.1016/j.ebiom.2019.10.011 
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Fig 5. Transcriptional features of HLA-DR + CD8 + T cells from cirrhotic patients. Following live/ dead exclusion, ﬂow cytometry sorted cells were assessed for the expression 
of 579 genes involved in immune responses using Nanostring TM technology. Gene expression is reported in HLA-DR + CD8 + T cells from cirrhotic patients as fold change of 
detected mRNA expression levels normalised to baseline values observed in HLA-DR −CD8 + paired samples ( n = 3, CLD patients; n = 2, AD patients; n = 1)): (a) Heat-map 
created using Java TreeView 1.1.6r4 representing statistically signiﬁcant transcriptional changes between HLA-DR + and HLA-DR − CD8 + T cells in cirrhotic patients ( n = 3). (b) 
Relevant transcriptional changes between HLA-DR + and HLA-DR − CD8 + T cells in cirrhotic patients. (c) Ex-vivo apoptosis staining performed to explore levels of apoptosis in 
HLA-DR + and HLA-DR −CD8 + T cells from cirrhotic patients ( n = 8). ∗ p < 0.05; • p < 0.1 (Wilcoxon signed-rank test). 
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c   cells, HLA-DR + CD8 + T cells lack the expression of invariant TCR
eceptors V α24J α18 and V α7.2J α33, distinguishing them from NKT
nd MAIT cells, respectively ( Fig. 4 e). 
.8. Transcriptional analyses reveal an impairment of 
ro-inﬂammatory pathways in HLA-DR + CD8 + T cells from cirrhotic 
atients 
Nanostring transcriptional analysis revealed 29 signiﬁcantly dif-
erentially expressed genes between paired HLA-DR + and their
LA-DR − counterparts in cirrhotic patients ( Fig. 5 a and 5 b). Be-
ides the signiﬁcant up-regulation of genes coding for HLA proteins
n the HLA-DR + subset, we report an up-regulation of granzyme
 ( GZMK ) coding gene. Conversely, levels of genes involved in cy-
okine production and intracellular signalling ( IL -15, IL -23A, IL6-
T, LTA, TGFB2R ), genes involved in JAK/STAT ( CISH, SOCS1 ) and
F κB pathways ( RELB, BCL2, ATM ) were diminished. Transcriptomic
nalysis also suggested impairment in the TNF- α signalling path-
ay with a signiﬁcant down-regulation of LTA, IL15, MAP4K2 and a
rend to a decreased expression of TNFSF4, TNFSF13B ( Fig. 5 a and
 b). Similarly, signiﬁcant alteration in expression of genes asso-
iated with TNF- α signalling pathways, cytokines production and
ignalling were noted in the HLA-DR + subset from HV ( Fig. S3 a). 
.9. HLA-DR + CD8 + T cells display low levels of apoptosis 
Having deﬁned phenotypic and transcriptomic alterations, we
hen assessed levels of apoptosis in HLA-DR + CD8 + T cells. Despite
 higher rate of Annexin + 7-AAD – cells in the HLA-DR + subset
rom patients compared to paired HLA-DR −, the proportions re-
ained subtle (median 0.68% and 0.10%; respectively, p = 0.008)
 Fig. 5 c). This was also the case in the HLA-DR + cells from HV ( Fig.
3 b). Please cite this article as: F. Lebossé, C. Gudd and E. Tunc et al., CD8+ T
contribute to cirrhosis-associated immune dysfunction, EBioMedicine, h.10. HLA-DR + CD8 + T cells from cirrhotic patients show a diminished 
apacity to induce proliferation of autologous PBMCs 
Functional assay to test the effect of HLA-DR + CD8 + T cells on
he proliferation of autologous CFSE-stained PBMCs in vitro showed
hat HLA-DR + CD8 + T cells from cirrhotic patients induced lower
evels of total PBMC proliferation in comparison to their HLA-DR −
ounterparts ( Fig. 6 a). Blockade of the immune checkpoints CTLA-
, PD-1 and TIM-3 failed to improve this proliferation ( Fig. 6 a).
imilarly, proliferation of PBMCs from HV was signiﬁcantly im-
aired in the presence of autologous HLA-DR + CD8 + T cells and
as not reversed following blockade of the inhibitory markers ( Fig.
2 d). In contrast, CTLA-4 blockade resulted in a signiﬁcant increase
f TNF- α in co-cultures of autologous PBMCs with HLA-DR + CD8 + 
 cells from cirrhotic patients ( Fig. 6 b). 
.11. In vitro , HLA-DR + CD8 + T cells from patients alter the phenotype 
nd function of autologous myeloid cells 
We investigated the impact of HLA-DR + CD8 + T cells on myeloid
ells using an in vitro co-culture system. We demonstrated that
ollowing 72hr of culture in the presence of 25% of plasma de-
ived from AD patients, isolated CD8 + T cells from HV had en-
anced HLA-DR expression, mimicking the ex vivo phenotype
 Fig. 7 a). The conditioned cells were then co-cultured with au-
ologous neutrophils or monocytes. Co-cultures with neutrophils
esulted in a signiﬁcantly lower expression of activation markers
CD16 and CD11B) ( Fig. 7 b). Additionally, the phagocytosis abil-
ty of the co-cultured neutrophils was signiﬁcantly impaired but
artially restored when the HLA-DR + subset was removed prior
o initiating co-culture ( Fig. 7 c). Following LPS stimulation, neu-
rophils co-cultured with HLA-DR + CD8 + T cells exhibited a signif-
cant decrease in their capacity to produce TNF- α ( Fig. 7 d). When
o-cultured with HLA-DR + CD8 + T cells, monocytes displayed an cells from patients with cirrhosis display a phenotype that may 
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Fig 6. HLA-DR + CD8 + T cells are less potent at inducing autologous PBMCs’ proliferation. (a) Proliferation in vitro of total autologous PBMCs in the presence of pre-isolated 
HLA-DR + or HLA-DR −CD8 + T cells from cirrhotic patients ( n = 7; CLD patients; n = 3, AD patients; n = 4) (1:2 HLA-DR + or HLA-DR − CD8 + T cell to PBMCs ratio) (left panel). 
The impact of surface inhibitory receptors blockade to restore the proliferation was tested in the presence of HLA-DR + CD8 + T cells and autologous PBMCs from cirrhotic 
patients (total n = 6; AD patients; n = 3, CLD patients; n = 3) (right panel). (b) Inhibitory receptor blockade was followed by assessment of cytokines production ( n = 4). ∗
p < 0.05 (Wilcoxon signed-rank test (a), Paired t-test (b)). 
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H  immunosuppressive phenotype characterized by signiﬁcantly in-
creased levels of MER-TK and PD-1 expression ( Fig. 7 e). 
4. Discussion 
We report a detailed phenotypical and functional description
of CD8 + T cells in cirrhosis revealing an expansion of an HLA-
DR + CD8 + T cell subset in peripheral, peritoneal and intrahepatic
compartments in this group of patients. Moreover, this HLA-DR high 
phenotype showed elevated levels of inhibitory receptors (CTLA-
4, PD-1 and TIM-3). Proportions and inhibitory proﬁle of periph-Please cite this article as: F. Lebossé, C. Gudd and E. Tunc et al., CD8+ 
contribute to cirrhosis-associated immune dysfunction, EBioMedicine, hral HLA-DR + CD8 + T cells were associated with infections and
oor disease outcomes. Our ﬁndings provide transcriptional ba-
is for the functional properties of the HLA-DR + CD8 + T cells iso-
ated from cirrhotic patients. We also shed light on the interac-
ion of this population with PBMCs and myeloid cells and their
ossible contribution to impaired innate immune responses in
irrhosis. 
It is of signiﬁcance that recent ﬁndings demonstrate the ex-
ansion of a similar phenotype in a cohort of patients with septic
hock. Mouillaux et al. showed an expansion of PD1-co-expressing
LA-DR T cells with impaired function following TCR activationT cells from patients with cirrhosis display a phenotype that may 
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Fig 7. Interaction between HLA-DR + CD8 + T cells and autologous neutrophils and monocytes (a) CD8 + T from HV cultured for 3 days in the presence of 25% plasma derived 
from AD patients ( n = 8) induces a similar phenotype to the ex vivo CD8 + T cells from cirrhotic patients contrary to HV CD8 + T cells cultured in the presence of 25% HV 
plasma ( n = 10). (b) Phenotype of autologous fresh neutrophils following 24 hr co-culture with AD cirrhotic-plasma (HLA-DR high ) vs HV-plasma (HLA-DR low ) treated CD8 + T 
cells. (c) Phagocytic ability of neutrophils following 4 h co-culture with HLA-DR high vs HLA-DR low CD8 + T cells (left panel) as well as following the removal of HLA-DR high from 
total CD8 + T cell population (right panel). (d) Cytokine productions in neutrophils following 4 h of co-culture. (e) Phenotypic changes on co-cultured monocytes with plasma 
pre-conditioned CD8 + T cells (HV-plasma ( n = 4) and AD cirrhotic patients plasma ( n = 7)) at 24 h. ∗ p < 0.05. (Wilcoxon signed-rank test (a;b;d;e), Paired t-test (c)). 
[  
d  
t  
t  
c
 
(  
g  
e  
p  
t  
t  
e  
o  
p  
b  
s  
s  
c  
p  
t  
D
 
M  
s  
a  
s  
o  
p  
p  
c  
b  
f  
F  
c  
b  
s  
b  
u  
t  
D
 
p  
g  
t  
S  
p  
W  
a  
r  
c  
T  
i  
e  
t  
t  
H  
a  20] . These data, described in another model of systemic immune
ysfunction, reinforces our observations and add further emphasis
o the role of TCR activation in the initiation of this phenotype and
he induction of immune alterations in this population of CD8 + T
ells. 
Elevated surface expression of immune checkpoint molecules
PD-1, CTLA-4 and TIM-3) on the HLA-DR + CD8 + T cells was sug-
estive of an exhausted T cell proﬁle. Recent observations how-
ver have referred to up-regulation of checkpoint receptors cou-
led with reduction in functions as a sign of functional adaptation
o a chronically inﬂamed milieu rather than signs of T cell exhaus-
ion [21] . Additionally, one of the distinguishing features between
xhausted and “non-functional” cells is the reversibility and regain
f functions following blockade of inhibitory receptors in the latter
opulations [22] . The data presented here suggest a role of CTLA-4
lockade in restoring TNF- α production. Previous studies have also
hown that in the context of AAH, blockade of highly expressed
urface inhibitory receptors PD-1 and TIM-3 on CD4 + and CD8 + T
ells enabled the restoration of cytokines production [10] . As op-
osed to exhausted T cells which exhibit increased levels of apop-
osis, susceptibility to apoptosis was not detected in activated HLA-
R High T cells in cirrhosis. 
Although well known for their antigen presentation capacity,
HC class II molecule expression on activated T cells have been
hown to trigger a variety of signalling pathways inducing both
poptosis and clonal anergy leading to failure to respond to sub-
equent antigenic stimuli [23,24] . When ﬁrst described, naturally
ccurring HLA-DR + CD8 + regulatory T cells were postulated to ex-
and following interaction with foreign antigens and their sup-Please cite this article as: F. Lebossé, C. Gudd and E. Tunc et al., CD8+ T
contribute to cirrhosis-associated immune dysfunction, EBioMedicine, hressive capacity was demonstrated to be CTLA-4-mediated [16] . In
irrhosis, bacterial translocation as well as bacterial products have
een shown to be implicated in the impairment of innate immune
unction and could play a role in the induction of this phenotype.
urthermore, in view of the importance of the inﬂammatory mi-
roenvironment in modulating immune cell function and as proven
y the mimicking of the ex vivo phenotype following in vitro expo-
ure to patients sera, it is likely that this phenotype is also driven
y soluble mediators in the circulation. The precise factors are still
nclear and remain to be investigated. More studies are necessary
o investigate the mechanisms underpinning the induction of HLA-
R expression on CD8 + T cells in cirrhosis. 
Transcriptional analysis of HLA-DR + CD8 + T cells reﬂected the
henotypical changes and highlighted a global down-regulation in
ene expression including genes involved in pro-inﬂammatory cy-
okines production and intracellular signalling ( IL -15, IL -23A, IL6-
T, LTA, TGFB2R ). Notably, TNF- α signalling pathways seemed im-
aired in HLA-DR + CD8 + T cells compared to HLA-DR −CD8 + T cells.
ith the exception of HLA-coding genes, much fewer genes (such
s Granzyme K ( GZK )) were up-regulated. GZK has been previously
eported to be over-expressed in a particular subset of CD8 + T
ells isolated by single-cell sequencing of liver cancer-inﬁltrating
 cells where different clusters of inﬁltrating CD8 + T cells were
dentiﬁed according to transcriptional features and notably a GZK -
xpressing cluster sharing some exhausted transcriptional charac-
eristics with uncommon activation markers but different from the
ypical exhausted CD8 + cluster [25] . Identiﬁcation of expanded
LA-DR + CD8 + T cells in other chronic inﬂammatory conditions
nd full characterization of their gene expression proﬁle are nec- cells from patients with cirrhosis display a phenotype that may 
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 essary before deﬁning a gene expression signature speciﬁc to cir-
rhosis. 
Despite the association between recent alcohol intake and TIM-
3 expression on CD8 + T cells in the most severe group of patients
(AD), it is worth noting that there were no other detectable differ-
ences in the phenotype of the CD8 + T cells based on disease aeti-
ology. Correlations between TIM-3 expression in total CD8 + T cells
and the severity of liver disease corroborated the link between dis-
ease stage and CD8 + T cells dysfunctional proﬁle. Although no sig-
niﬁcant correlation between HLA-DR expression on CD8 + T cells
and MELD score were detected, circulating HLA-DR + CD8 + T cells
levels were higher in AD patients with concomitant sepsis sug-
gesting a possible contribution of this population to susceptibility
and/or impaired immune responses to infection episodes. There-
fore, monitoring the expansion of this CD8 + T cell subset could
serve as a potential immunomodulatory marker to facilitate the
discrimination of cirrhotic patients with high risk of developing in-
fection. Our ﬁnding that co-expression of HLA-DR and PD1 was a
predictor of outcome highlights that it is more often a panel of
biomarkers, as opposed to expression of a single molecule that is
more likely to identify patients at high risk. However, this study
only describes a cohort of 60 patients with cirrhosis; the clinical
utility of this phenotype should be measured in a larger cohort of
patients. Furthermore, our ﬁndings need to be validated in other
cohorts of liver disease patients, stratifying for disease aetiology
and using larger cohorts, followed over time. 
In accordance with previous reports [16,19] , HLA-DR + CD8 + T
cell subset reported in our study were immunomodulatory through
their capacity to induce weaker PBMCs proliferation compared to
their HLA-DR − counterparts. Sera-conditioning experiments high-
light the importance of the inﬂammatory milieu in driving the
predominant HLA-DR + CD8 + T cells phenotype in cirrhosis. The
role of the microenvironment in the induction of this phenotype
may also explain the functional differences observed between HLA-
DR + CD8 + T cells from cirrhotic patients and HV [16,17] . 
In our study, although it failed to restore proliferation, CTLA-
4 blockade enhanced levels of TNF- α production in PBMCs from
cirrhotic patients. Although the interplay between CD8 + T cells
and neutrophils have been previously demonstrated [26] , our study
is the ﬁrst to report an immunomodulatory role of dysfunctional
CD8 + T cells on PMNs in cirrhosis, particularly in regards to TNF- α
secretion. Indeed, we reveal further immune-regulatory functions
exerted by the HLA-DR high population on monocytes. We demon-
strate that HLA-DR + CD8 + T cells induced a regulatory monocyte
phenotype highlighted by higher MER-TK and PD-1 expression.
MER-TK + monocytes have been reported to increase in ACLF pa-
tients, correlate with disease severity and to display impaired pro-
inﬂammatory cytokines production [12] . Our in vitro data showing
induced-PD-1 expression in monocytes however requires further
studies to explore ex vivo expression levels of PD-1 on monocytes
from patients with cirrhosis. These ﬁndings strongly support the
hypothesis of an initial protective role of the dysfunctional CD8 + T
cells in cirrhotic patients following an excessive inﬂammation, by
inducing pro-resolution monocytes phenotype and lower activation
status of neutrophils. This however may have deleterious effects
on antimicrobial responses and contribute to subsequent impair-
ment in immune functions and poor disease outcomes in these
patients. This is further emphasized by the presence of this phe-
notype in the peritoneal compartment, which may contribute to
susceptibility to spontaneous bacterial peritonitis. Intrahepatic im-
mune cells play an important role in immune surveillance. The ex-
pansion of this phenotype which we observed in the liver could
play a role in susceptibility to infection-mediated decompensation
in liver disease. However, implying immune biology in liver dis-
eases based on peripheral evaluation of immune markers, as op-
posed to full evaluation of liver inﬁltrating lymphocytes for exam-Please cite this article as: F. Lebossé, C. Gudd and E. Tunc et al., CD8+ 
contribute to cirrhosis-associated immune dysfunction, EBioMedicine, hle, has a potential for ﬁndings that are not always reﬂective of
epatic immunobiology. Utilizing single-cell molecular approaches
ave opened up new opportunities to surpass descriptive studies
n health and disease. Ramachandran et al. have highlighted the
tility of single-cell RNA-sequencing in dissecting mechanisms reg-
lating human liver cirrhosis by uncovering 3 novel subsets in-
olved in the pathogenesis of liver ﬁbrosis including TREM2 + CD9 + 
acrophages, ACKR1 + and PLVAP + endothelial cells and PDGFR α+ 
ollagen producing myoﬁbroblasts [27] . Such studies deepen our
nderstanding of pathogenic mechanisms of human disorders and
rovide novel insights into the design of therapeutic targets. 
Altogether, we demonstrate for the ﬁrst time a dysfunctional
D8 + T cell population in cirrhosis mainly deﬁned by a pre-
ominant HLA-DR + CD8 + T cells subset displaying exhausted, acti-
ated and immune-modulatory properties. Speciﬁc mediators driv-
ng these alterations and the relevance of this population in clinical
ractice remain to be explored in further studies. 
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